In addition, the pharmacology with the Energetic factors was largely uncharacterized, and confirmation of SCB use was hindered by an absence of recognised biomarkers. These understanding gaps prompted experts throughout various disciplines to quickly (1) monitor, determine and quantify with chromatography/mass spectrometry the at any time-switching